Brain angiogenesis inhibitor 1 (BAI1) is a pattern recognition receptor that mediates macrophage binding and engulfment of Gram-negative bacteria.
Bacterial recognition by host cells is essential for initiation of infection and the host response. Bacteria interact with host cells via multiple pattern recognition receptors that recognize microbial products or pathogen-associated molecular patterns. In response to this interaction, host cell signaling cascades are activated that lead to inflammatory responses and/or phagocytic clearance of attached bacteria. Brain angiogenesis inhibitor 1 (BAI1) is a receptor that recognizes apoptotic cells through its conserved type I thrombospondin repeats and triggers their engulfment through an ELMO1/Dock/Rac1 signaling module. Because thrombospondin repeats in other proteins have been shown to bind bacterial surface components, we hypothesized that BAI1 may also mediate the recognition and clearance of pathogenic bacteria. We found that preincubation of bacteria with recombinant soluble BAI1 ectodomain or knockdown of endogenous BAI1 in primary macrophages significantly reduced binding and internalization of the Gram-negative pathogen Salmonella typhimurium. Conversely, overexpression of BAI1 enhanced attachment and engulfment of Salmonella in macrophages and in heterologous nonphagocytic cells. Bacterial uptake is triggered by the BAI1-mediated activation of Rac through an ELMO/Dock-dependent mechanism, and inhibition of the BAI1/ELMO1 interaction prevents both Rac activation and bacterial uptake. Moreover, inhibition of ELMO1 or Rac function significantly impairs the proinflammatory response to infection. Finally, we show that BAI1 interacts with a variety of Gram-negative, but not Gram-positive, bacteria through recognition of their surface lipopolysaccharide. Together these findings identify BAI1 as a pattern recognition receptor that mediates nonopsonic phagocytosis of Gram-negative bacteria by macrophages and directly affects the host response to infection.
Departments of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Soumita
S
Das
Katherine A
KA
Owen
Kim T
KT
Ly
Daeho
D
Park
Steven G
SG
Black
Jeffrey M
JM
Wilson
Costi D
CD
Sifri
Kodi S
KS
Ravichandran
Peter B
PB
Ernst
James E
JE
Casanova
D042501:Angiogenic Proteins / Q000502:physiology*; D000818:Animals; D001422:Bacterial Adhesion; D015153:Blotting, Western; D004797:Enzyme-Linked Immunosorbent Assay; D008264:Macrophages / Q000382:microbiology*; D051379:Mice; D012486:Salmonella typhimurium / Q000502:physiology*
C524949:Adgrb1 protein, mouse; D042501:Angiogenic Proteins
Mucosal Immunol. 2008 Nov;1 Suppl 1:S10-4
19079220
J Immunol. 2009 Apr 15;182(8):4616-23
19342636
Oncogene. 1997 Oct;15(18):2145-50
9393972
FEBS Lett. 2007 Jan 23;581(2):325-30
17222412
Nat Immunol. 2007 Oct;8(10):1086-94
17873879
FASEB J. 2007 Oct;21(12):3118-32
17507668
Sci Signal. 2009 May 26;2(72):re3
19471024
J Cell Biol. 2002 Oct 28;159(2):373-82
12391027
Annu Rev Biochem. 2002;71:635-700
12045108
FEMS Immunol Med Microbiol. 1998 Feb;20(2):89-97
9544775
Nature. 2007 Nov 15;450(7168):430-4
17960134
Annu Rev Biochem. 2007;76:447-80
17328678
Infect Immun. 2003 May;71(5):2885-91
12704163
J Immunol. 2008 Sep 1;181(5):3575-85
18714031
Nature. 2009 Apr 30;458(7242):1191-5
19252480
J Immunol. 2008 Nov 15;181(10):7147-56
18981136
Nat Immunol. 2004 Oct;5(10):987-95
15454922
Mol Microbiol. 1998 Oct;30(1):47-56
9786184
Nat Immunol. 2004 Jan;5(1):88-97
14691481
Glycobiology. 2009 Jun;19(6):568-75
19287024
J Cell Sci. 2001 Apr;114(Pt 7):1331-41
11256999
Science. 1998 Nov 27;282(5394):1717-21
9831565
Nature. 1997 Nov 27;390(6658):350-1
9389474
Immunity. 2008 Jul 18;29(1):12-20
18631453
Annu Rev Immunol. 2005;23:901-44
15771589